Back to User profile » Dr Kunihiro Asanuma
Papers published by Dr Kunihiro Asanuma:
Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study
Nakamura T, Asanuma K, Takao M, Yamanaka T, Koike H, Chen-Yoshikawa TF, Tsukushi S, Kuroda H, Kozawa E, Sano M, Aiba H, Nakanishi R, Nagano A, Yamada K, Shido Y, Kawanami K, Izubuchi Y, Sudo A, Nishida Y
Cancer Management and Research 2021, 13:8473-8480
Published Date: 10 November 2021
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan
Nakamura T, Asanuma K, Hagi T, Sudo A
Drug Design, Development and Therapy 2020, 14:4215-4220
Published Date: 12 October 2020
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
Nakamura T, Sugaya J, Naka N, Kobayashi H, Okuma T, Kunisada T, Asanuma K, Outani H, Nishimura S, Kawashima H, Akiyama T, Yasuda T, Miwa S, Sudo A, Ueda T
Cancer Management and Research 2020, 12:10017-10022
Published Date: 12 October 2020
Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma
Okuno K, Matsubara T, Nakamura T, Iino T, Kakimoto T, Asanuma K, Matsumine A, Sudo A
OncoTargets and Therapy 2018, 11:6879-6886
Published Date: 12 October 2018
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A
OncoTargets and Therapy 2017, 10:559-564
Published Date: 31 January 2017